BEX2 promotes tumor proliferation in colorectal cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28367093)

Published in Int J Biol Sci on February 12, 2017

Authors

Yeting Hu1, Qian Xiao1, Haiyan Chen1, Jinjie He1, Yinuo Tan1, Yue Liu1, Zhanhuai Wang1, Qi Yang1, Xiangfeng Shen1, Yu Huang2, Ying Yuan3, Kefeng Ding1

Author Affiliations

1: Department of Surgical Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;; Key Laboratory of Cancer Prevention and Intervention of the China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences of Zhejiang Province, Cancer Institute, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
2: Laboratory Animal Research Center, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
3: Key Laboratory of Cancer Prevention and Intervention of the China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences of Zhejiang Province, Cancer Institute, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Articles cited by this

Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28

Cetuximab for the treatment of colorectal cancer. N Engl J Med (2007) 13.39

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A (2001) 11.06

Asia Pacific consensus recommendations for colorectal cancer screening. Gut (2008) 3.19

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clin Cancer Res (2009) 3.08

TNM residual tumor classification revisited. Cancer (2002) 2.50

Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res (2006) 1.50

Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol (2007) 1.44

Panitumumab. Nat Rev Drug Discov (2006) 1.31

Characterization of the Bex gene family in humans, mice, and rats. Gene (2005) 1.14

Orthotopic mouse model of colorectal cancer. J Vis Exp (2007) 1.11

Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: comparison with manual counting. Int J Radiat Biol (2011) 1.09

Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia (2009) 1.07

BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer. Int J Cancer (2010) 1.02

BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer. Mol Cancer (2010) 0.96

Colorectal Cancer Treatment: What's Next? (or: Is There Life After EGFR and VEGF?). Gastrointest Cancer Res (2008) 0.90

Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cells. Carcinogenesis (2008) 0.90

Human Bex2 interacts with LMO2 and regulates the transcriptional activity of a novel DNA-binding complex. Nucleic Acids Res (2005) 0.88

Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway. Biochem Biophys Res Commun (2012) 0.87

BEX1 acts as a tumor suppressor in acute myeloid leukemia. Oncotarget (2015) 0.85

BEX1 promotes imatinib-induced apoptosis by binding to and antagonizing BCL-2. PLoS One (2014) 0.85

Brain expressed and X-linked (Bex) proteins are intrinsically disordered proteins (IDPs) and form new signaling hubs. PLoS One (2015) 0.84

Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway. J Mol Neurosci (2014) 0.82

Brain-Expressed X-linked (BEX) proteins in human cancers. Biochim Biophys Acta (2015) 0.82